Tcg Crossover Management, LLC Portfolio Holdings

Tcg Crossover Management, LLC

  • $771 Million
  • Q3 2024

Tcg Crossover Management, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $771 Million distributed in 36 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Dyne Therapeutics, Inc. with a value of $95.2M, Cogent Biosciences, Inc. with a value of $75.2M, Edgewise Therapeutics, Inc. with a value of $56.4M, Silence Therapeutics PLC with a value of $55.2M, and Savara Inc with a value of $52.4M.

Examining the 13F form we can see an increase of $103M in the current position value, from $668M to 771M.

Tcg Crossover Management, LLC is based out at Palo Alto, CA

Below you can find more details about Tcg Crossover Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $771 Million
Healthcare: $771 Million

Stock Holdings Table Market Cap. of $2 Billions to $10 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$2.02B
$56.4 Million 7.32% of portfolio
2,112,984
Q3 2024 Reduced 7.03%

Summary

  • Portfolio
  • No. of Stocks 36
  • Current Value $771 Million
  • Prior Value $668 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 9 stocks
  • Additional Purchases 2 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track Tcg Crossover Management, LLC Portfolio

Follow Tcg Crossover Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcg Crossover Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tcg Crossover Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email